|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang Y and Ajani JA: Multidisciplinary
management of gastric cancer. Curr Opin Gastroenterol. 26:640–646.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi W, Wang J, Zhang M, Yu C, He W and Liu
P: The multivariate prognostic analysis of 1340 gastric cancer
patients who received radical resection. J Nanjing Med Univ (Nat
Sci Ed). 31:1310–1315. 2010.
|
|
4
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the human
development index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pastorcic M, Wang H, Elbrecht A, Tsai SY,
Tsai MJ and O'Malley BW: Control of transcription initiation in
vitro requires binding of a transcription factor to the distal
promoter of the ovalbumin gene. Mol Cell Biol. 6:2784–2791. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang LH, Tsai SY, Cook RG, Beattie WG,
Tsai MJ and O'Malley BW: COUP transcription factor is a member of
the steroid receptor superfamily. Nature. 340:163–166. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sagami I, Tsai SY, Wang H, Tsai MJ and
O'Malley BW: Identification of two factors required for
transcription of the ovalbumin gene. Mol Cell Biol. 6:4259–4267.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyajima N, Kadowaki Y, Fukushige S,
Shimizu S, Semba K, Yamanashi Y, Matsubara K, Toyoshima K and
Yamamoto T: Identification of two novel members of erbA superfamily
by molecular cloning: The gene products of the two are highly
related to each other. Nucleic Acids Res. 16:11057–11074. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang LH, Tsai SY, Sagami I, Tsai MJ and
O'Malley BW: Purification and characterization of chicken ovalbumin
upstream promoter transcription factor from HeLa cells. J Biol
Chem. 262:16080–16086. 1987.PubMed/NCBI
|
|
10
|
Wang LH, Ing NH, Tsai SY, O'Malley BW and
Tsai MJ: The COUP-TFs compose a family of functionally related
transcription factors. Gene Expr. 1:207–216. 1991.PubMed/NCBI
|
|
11
|
Ladias JA and Karathanasis SK: Regulation
of the apolipoprotein AI gene by ARP-1, a novel member of the
steroid receptor superfamily. Science. 251:561–565. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin J, Wu SP, Creighton CJ, Dai F, Xie X,
Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, et al: COUP-TFII
inhibits TGF-β-induced growth barrier to promote prostate
tumorigenesis. Nature. 493:236–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin J, Chen X, Xie X, Tsai MJ and Tsai SY:
COUP-TFII regulates tumor growth and metastasis by modulating tumor
angiogenesis. Proc Natl Acad Sci USA. 107:pp. 3687–3692. 2010;
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin J, Chen X, Yu-Lee LY, Tsai MJ and Tsai
SY: Nuclear receptor COUP-TFII controls pancreatic islet tumor
angiogenesis by regulating vascular endothelial growth
factor/vascular endothelial growth factor receptor-2 signaling.
Cancer Res. 70:8812–8821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Polvani S, Tarocchi M, Tempesti S, Mello
T, Ceni E, Buccoliero F, D'Amico M, Boddi V, Farsi M, Nesi S, et
al: COUP-TFII in pancreatic adenocarcinoma: Clinical implication
for patient survival and tumor progression. Int J Cancer.
134:1648–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hawkins SM, Loomans HA, Wan YW,
Ghosh-Choudhury T, Coffey D, Xiao W, Liu Z, Sangi-Haghpeykar H and
Anderson ML: Expression and functional pathway analysis of nuclear
receptor NR2F2 in ovarian cancer. J Clin Endocrinol Metab.
98:E1152–E1162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bao Y, Gu D, Feng W, Sun X, Wang X, Zhang
X, Shi Q, Cui G, Yu H, Tang C and Deng A: COUP-TFII regulates
metastasis of colorectal adenocarcinoma cells by modulating Snail1.
Br J Cancer. 111:933–943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu YM, Hu XP, Zhang L, Zhang SS and Xu JM:
Uptake characteristics of levofloxacin for the eradication of
Helicobacter pylori by GES-1 and MGC80-3 cells. Eur Rev Med
Pharmacol Sci. 20:486–490. 2016.PubMed/NCBI
|
|
20
|
Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma
H, Yu D, Maitikabili A, Xiao H, Zhang C, et al: MicroRNA-543
suppresses colorectal cancer growth and metastasis by targeting
KRAS, MTA1 and HMGA2. Oncotarget. 7:21825–21839. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Zhang Y, Ding W, Lin Y, Huang Z
and Luo Q: MiR-33a suppresses breast cancer cell proliferation and
metastasis by targeting ADAM9 and ROS1. Protein Cell. 6:881–889.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Xu G, Liu G, Ye Y, Zhang C, Fan
C, Wang H, Cai H, Xiao R, Huang Z and Luo Q: miR-411-5p inhibits
proliferation and metastasis of breast cancer cell via targeting
GRB2. Biochem Biophys Res Commun. 476:607–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McKenna NJ and O'Malley BW: Combinatorial
control of gene expression by nuclear receptors and coregulators.
Cell. 108:465–474. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Navab R, Gonzalez-Santos JM, Johnston MR,
Liu J, Brodt P, Tsao MS and Hu J: Expression of chicken ovalbumin
upstream promoter-transcription factor II enhances invasiveness of
human lung carcinoma cells. Cancer Res. 64:5097–5105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Safe S, Jin UH, Hedrick E, Reeder A and
Lee SO: Minireview: Role of orphan nuclear receptors in cancer and
potential as drug targets. Mol Endocrinol. 28:157–172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu H and Xu Y: Recent advancement in
metastasis of gastric cancer. Chin J Prac. 31:666–669. 2011.
|
|
30
|
Nagasaki S, Suzuki T, Miki Y, Akahira J,
Shibata H, Ishida T, Ohuchi N and Sasano H: Chicken ovalbumin
upstream promoter transcription factor II in human breast
carcinoma: Possible regulator of lymphangiogenesis via vascular
endothelial growth factor-C expression. Cancer Sci. 100:639–645.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu M, Qin J, Tsai SY and Tsai MJ: The role
of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta
Pharmacol Sin. 36:32–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ
and Tsai SY: Direct transcriptional regulation of neuropilin-2 by
COUP-TFII modulates multiple steps in murine lymphatic vessel
development. J Clin Invest. 120:1694–1707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang S, Chen F, Zhang C, Gu X and Chen M:
Establishment of liver metastasis model in nude mice with human
gastric carcinoma. Beijing Lab Anim Sci. 9:131992.
|
|
34
|
Shan F, Li Z, Bu Z, Zhang L, Wu A, Wu X,
Wu Qi, Zong X, Li S, Ji X, Wu J and Ji J: The analysis of gastric
cancer staging AJCC 6th edition and 7th edition. Chin J Prac Surg.
31:675–680. 2011.
|
